Actinogen Medical

Ticker ACW

Exchange ASX More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Sydney, Australia

Actinogen Medical is an ASX-listed biotechnology company developing novel therapies for neurological diseases associated with dysregulated brain cortisol.Actinogen Medical’s lead compound, Xanamem®, has been specifically designed to reduce production of intracellular cortisol - the stress hormone - through the inhibition of the 11β-HSD1 enzyme in the brain.

Visit website

REPORT RATINGS

4.8 / 5.0 (84)

Actinogen Medical reports have an aggregate usefulness score of 4.8 based on 84 reviews.

Actinogen Medical